Keller Deborah L
Insider transactions at 2 companies
This page shows all SEC Form 4 filings attributed to Keller Deborah L. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| WST | Award / Grant | 1,071 | — | — | May 6, 2025 | |
| WST | Award / Grant | 564 | — | — | Apr 23, 2024 | |
| WST | Award / Grant | 616 | — | — | Apr 25, 2023 | |
| WST | Award / Grant | 632 | — | — | May 24, 2022 | |
| WST | Award / Grant | 577 | — | — | May 4, 2021 | |
| WST | Award / Grant | 975 | — | — | May 5, 2020 | |
| WST | Award / Grant | 1,565 | — | — | May 7, 2019 | |
| WST | Award / Grant | 1,824 | — | — | May 1, 2018 | |
| WST | Award / Grant | 1,483 | — | — | Jun 1, 2017 | |
| LH | CEO, Covance Drug Development | Tax Withholding | 4,213 | $115.49 | $486,559 | Mar 11, 2016 |
| 0001023131 | Corp. Executive Vice President | Award / Grant | 4,190 | — | — | Feb 19, 2015 |
| 0001023131 | Corp. Executive Vice President | Tax Withholding | 3,692 | $102.61 | $378,836 | Dec 17, 2014 |
| 0001023131 | Corp. Executive Vice President | Option Exercise | 400 | $62.65 | $25,060 | Dec 5, 2014 |
| 0001023131 | Corp. Executive Vice President | Award / Grant | 11,460 | — | — | Feb 18, 2014 |
| 0001023131 | Corp. Executive Vice President | Option Exercise | 11,100 | $39.80 | $441,780 | Feb 7, 2014 |
| 0001023131 | Corp. Executive Vice President | Tax Withholding | 2,545 | $84.31 | $214,569 | Dec 17, 2013 |
| 0001023131 | Corp. Executive Vice President | Option Exercise | 2,500 | $42.32 | $105,800 | Aug 21, 2013 |